1225. In Vitro Activity of Aztreonam-Avibactam and Comparator Agents Against Enterobacterales Collected from Geriatric Patients in ICU and non-ICU wards, ATLAS Surveillance Program 2016-2019

BACKGROUND: Elevated resistance rates have been reported in ICUs. Aztreonam (ATM) combined with avibactam (AVI) is being developed for use against drug-resistant Enterobacterales (Ebact), including metallo-β-lactamase (MBL)-positive isolates. We examined the activity of ATM-AVI and comparators again...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Kazmierczak, Krystyna, Arhin, Francis, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644095/
http://dx.doi.org/10.1093/ofid/ofab466.1417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644095/
http://dx.doi.org/10.1093/ofid/ofab466.1417

Ejemplares similares